BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20798208)

  • 1. Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy.
    Pattani KM; Zhang Z; Demokan S; Glazer C; Loyo M; Goodman S; Sidransky D; Bermudez F; Jean-Charles G; McCaffrey T; Padhya T; Phelan J; Spivakovsky S; Bowne HY; Goldberg JD; Rolnitzky L; Robbins M; Kerr AR; Sirois D; Califano JA
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1093-103. PubMed ID: 20798208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions.
    Schussel J; Zhou XC; Zhang Z; Pattani K; Bermudez F; Jean-Charles G; McCaffrey T; Padhya T; Phelan J; Spivakovsky S; Brait M; Li R; Bowne HY; Goldberg JD; Rolnitzky L; Robbins M; Kerr AR; Sirois D; Califano JA
    Clin Cancer Res; 2013 Jun; 19(12):3268-75. PubMed ID: 23637120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses.
    Demokan S; Chang X; Chuang A; Mydlarz WK; Kaur J; Huang P; Khan Z; Khan T; Ostrow KL; Brait M; Hoque MO; Liegeois NJ; Sidransky D; Koch W; Califano JA
    Int J Cancer; 2010 Nov; 127(10):2351-9. PubMed ID: 20162572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation in Indian primary oral squamous cell carcinoma.
    Kaur J; Demokan S; Tripathi SC; Macha MA; Begum S; Califano JA; Ralhan R
    Int J Cancer; 2010 Nov; 127(10):2367-73. PubMed ID: 20473870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva.
    Guerrero-Preston R; Soudry E; Acero J; Orera M; Moreno-López L; Macía-Colón G; Jaffe A; Berdasco M; Ili-Gangas C; Brebi-Mieville P; Fu Y; Engstrom C; Irizarry RA; Esteller M; Westra W; Koch W; Califano J; Sidransky D
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1061-72. PubMed ID: 21558411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for oral premalignancy and cancer: what platform and which biomarkers?
    Lingen MW
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1056-9. PubMed ID: 20798207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation in primary squamous cell carcinoma of the oral cavity and oropharynx: a study of a Brazilian cohort.
    de Freitas Cordeiro-Silva M; Stur E; Agostini LP; de Podestá JR; de Oliveira JC; Soares MS; Mendonça EF; Gouvea SA; Von Zeidler SV; Louro ID
    Mol Biol Rep; 2012 Dec; 39(12):10111-9. PubMed ID: 22936053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative study.
    Roh JL; Wang XV; Manola J; Sidransky D; Forastiere AA; Koch WM
    Clin Cancer Res; 2013 May; 19(9):2528-40. PubMed ID: 23444219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-expression of the methylated EDNRB gene in oral squamous cell carcinoma attenuates cancer-induced pain.
    Viet CT; Ye Y; Dang D; Lam DK; Achdjian S; Zhang J; Schmidt BL
    Pain; 2011 Oct; 152(10):2323-2332. PubMed ID: 21782343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant promoter methylation of EDNRB in lung cancer in Taiwan.
    Chen SC; Lin CY; Chen YH; Fang HY; Cheng CY; Chang CW; Chen RA; Tai HL; Lee CH; Chou MC; Lin TS; Hsu LS
    Oncol Rep; 2006 Jan; 15(1):167-72. PubMed ID: 16328051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma.
    Zhao BJ; Sun DG; Zhang M; Tan SN; Ma X
    Dis Esophagus; 2009; 22(1):55-61. PubMed ID: 18564167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of endothelin receptor type B promoter methylation as a biomarker for the risk assessment and diagnosis of prostate cancer: A meta-analysis.
    Yuan Y; Du Y; Wang L; Liu X
    Pathol Res Pract; 2020 Feb; 216(2):152796. PubMed ID: 31926772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance.
    Carvalho AL; Henrique R; Jeronimo C; Nayak CS; Reddy AN; Hoque MO; Chang S; Brait M; Jiang WW; Kim MM; Claybourne Q; Goldenberg D; Khan Z; Khan T; Westra WH; Sidransky D; Koch W; Califano JA
    Clin Cancer Res; 2011 Jul; 17(14):4782-9. PubMed ID: 21628494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity.
    Nomura H; Uzawa K; Ishigami T; Kouzu Y; Koike H; Ogawara K; Siiba M; Bukawa H; Yokoe H; Kubosawa H; Tanzawa H
    BMC Cancer; 2008 Feb; 8():39. PubMed ID: 18237446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India.
    Reddy VR; Annamalai T; Narayanan V; Ramanathan A
    Asian Pac J Cancer Prev; 2015; 16(4):1599-603. PubMed ID: 25743838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation analysis of cancer-related genes in non-neoplastic cells from patients with oral squamous cell carcinoma.
    de Freitas Cordeiro-Silva M; Oliveira ZF; de Podestá JR; Gouvea SA; Von Zeidler SV; Louro ID
    Mol Biol Rep; 2011 Nov; 38(8):5435-41. PubMed ID: 21380558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer.
    Chen C; Wang L; Liao Q; Huang Y; Ye H; Chen F; Xu L; Ye M; Duan S
    Diagn Pathol; 2013 Dec; 8():199. PubMed ID: 24326135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
    Cao J; Zhou J; Gao Y; Gu L; Meng H; Liu H; Deng D
    Clin Cancer Res; 2009 Aug; 15(16):5178-83. PubMed ID: 19671846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Stem Cell based molecular predictors of tumor recurrence in Oral squamous cell carcinoma.
    Mohanta S; Sekhar Khora S; Suresh A
    Arch Oral Biol; 2019 Mar; 99():92-106. PubMed ID: 30641296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
    Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
    Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.